Literature DB >> 21538986

Alternative methods for testing treatment effects on the basis of multiple outcomes: simulation and case study.

Frank B Yoon1, Garrett M Fitzmaurice, Stuart R Lipsitz, Nicholas J Horton, Nan M Laird, Sharon-Lise T Normand.   

Abstract

In clinical trials multiple outcomes are often used to assess treatment interventions. This paper presents an evaluation of likelihood-based methods for jointly testing treatment effects in clinical trials with multiple continuous outcomes. Specifically, we compare the power of joint tests of treatment effects obtained from joint models for the multiple outcomes with univariate tests based on modeling the outcomes separately. We also consider the power and bias of tests when data are missing, a common feature of many trials, especially in psychiatry. Our results suggest that joint tests capitalize on the correlation of multiple outcomes and are more powerful than standard univariate methods, especially when outcomes are missing completely at random. When outcomes are missing at random, test procedures based on correctly specified joint models are unbiased, while standard univariate procedures are not. Results of a simulation study are reported, and the methods are illustrated in an example from the Clinical Antipsychotic Trials of Intervention Effectiveness for schizophrenia.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538986      PMCID: PMC3116112          DOI: 10.1002/sim.4262

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

1.  Multivariate linear mixed models for multiple outcomes.

Authors:  M Sammel; X Lin; L Ryan
Journal:  Stat Med       Date:  1999 Sep 15-30       Impact factor: 2.373

2.  A scaled linear mixed model for multiple outcomes.

Authors:  X Lin; L Ryan; M Sammel; D Zhang; C Padungtod; X Xu
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

3.  Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues.

Authors:  Abdul J Sankoh; Ralph B D'Agostino; Mohammad F Huque
Journal:  Stat Med       Date:  2003-10-30       Impact factor: 2.373

4.  Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Authors:  Nick Freemantle; Melanie Calvert; John Wood; Joanne Eastaugh; Carl Griffin
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

5.  Scaled marginal models for multiple continuous outcomes.

Authors:  Jason Roy; Xihong Lin; Louise M Ryan
Journal:  Biostatistics       Date:  2003-07       Impact factor: 5.899

Review 6.  Clinical trials design lessons from the CATIE study.

Authors:  Helena Chmura Kraemer; Ira D Glick; Donald F Klein
Journal:  Am J Psychiatry       Date:  2009-10-01       Impact factor: 18.112

7.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

8.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

9.  Bayesian models for multiple outcomes nested in domains.

Authors:  Sally W Thurston; David Ruppert; Philip W Davidson
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

10.  Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.

Authors:  Jonathan M Meyer; Vicki G Davis; Donald C Goff; Joseph P McEvoy; Henry A Nasrallah; Sonia M Davis; Robert A Rosenheck; Gail L Daumit; John Hsiao; Marvin S Swartz; T Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Res       Date:  2008-02-06       Impact factor: 4.939

  10 in total
  6 in total

1.  The use and abuse of multiple outcomes in randomized controlled depression trials.

Authors:  Kristin M Tyler; Sharon-Lise T Normand; Nicholas J Horton
Journal:  Contemp Clin Trials       Date:  2010-12-23       Impact factor: 2.226

2.  Estimating scaled treatment effects with multiple outcomes.

Authors:  Edward H Kennedy; Shreya Kangovi; Nandita Mitra
Journal:  Stat Methods Med Res       Date:  2017-12-18       Impact factor: 3.021

3.  Impact of PCA strategies on pain intensity and functional assessment measures in adults with sickle cell disease during hospitalized vaso-occlusive episodes.

Authors:  Carlton D Dampier; Carrie G Wager; Ryan Harrison; Lewis L Hsu; Caterina P Minniti; Wally R Smith
Journal:  Am J Hematol       Date:  2012-08-07       Impact factor: 10.047

4.  The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders.

Authors:  Alisa B Busch; Frank Yoon; Colleen L Barry; Vanessa Azzone; Sharon-Lise T Normand; Howard H Goldman; Haiden A Huskamp
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

5.  Effectiveness of a Disability Preventive Intervention for Minority and Immigrant Elders: The Positive Minds-Strong Bodies Randomized Clinical Trial.

Authors:  Margarita Alegría; Walter Frontera; Mario Cruz-Gonzalez; Sheri Lapatin Markle; Chau Trinh-Shevrin; Ye Wang; Lizbeth Herrera; Rachel Zack Ishikawa; Esther Velazquez; Larimar Fuentes; Yuying Guo; Janet Pan; Megan Cheung; Jeanine Wong; Urania Genatios; Aida Jimenez; Zorangelí Ramos; Giselle Perez; Josephine Yankau Wong; Ching-King Chieng; Stephen J Bartels; Naihua Duan; Patrick E Shrout
Journal:  Am J Geriatr Psychiatry       Date:  2019-08-13       Impact factor: 4.105

6.  The effects on depression of Internet-administered behavioural activation and physical exercise with treatment rationale and relapse prevention: study protocol for a randomised controlled trial.

Authors:  Per Carlbring; Philip Lindner; Christopher Martell; Peter Hassmén; Lars Forsberg; Lars Ström; Gerhard Andersson
Journal:  Trials       Date:  2013-02-02       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.